“Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice”. The Iraqi Journal of Veterinary Medicine, vol. 46, no. 2, Dec. 2022, pp. 53-65, https://doi.org/10.30539/ijvm.v46i2.1554.